Abstract

Background and PurposeThe low rate of internal mammary node (IMN) recurrence was attributed to systemic therapy and internal mammary chain (IMC) coverage by the tangential fields of irradiation. This study aimed to evaluate the incidental irradiation dose to the IMC in breast cancer patients after surgery and to estimate the clinical predictive parameters affecting the magnitude of the IMC.Materials and MethodsA total of 138 patients treated with postmastectomy radiotherapy and 210 patients undergoing radiotherapy after breast-conserving surgery (BCS) in our hospital were retrospectively analyzed. The mean dose (Dmean) to the IMC and the first to third intercostal spaces of IMC levels (ICS1–3) were evaluated. We evaluated the IMC coverage according to the type of surgery and whether the ipsilateral supraclavicular fossa (SCF) was included in the irradiation field.ResultsThe incidental radiation dose to the IMC was 29.69 Gy, and the dose delivered to the IMC, ICS1, and ICS2 showed a greater coverage in the modified radical mastectomy (MRM) group when compared with the BCS group (32.85 vs. 27.1 Gy, 26.6 vs. 12.5 Gy, 34.63 vs. 30.42 Gy). The dose delivered to ICS3 showed no difference between the MRM and BCS groups (37.41 vs. 36.24 Gy). Furthermore, 131 patients (37.64%) received radiotherapy to the chest wall and ipsilateral SCF. In the univariate analysis, both surgery type and SCF irradiation were parameters affecting the Dmean of incidental radiation to the IMC (r = −0.179, P = 0.001; r = −0.175, P = 0.001). In the multivariate analysis, surgery type was the only correlative factor that affected incidental radiation dose to the IMC (r = –3.534, P = 0.000).ConclusionThe real influencing factor of incidental dose to the IMC was the surgery form rather than the accession of SCF irradiation.

Highlights

  • Adjuvant breast cancer radiotherapy reduces the risk of local/ regional recurrence and improves overall survival (OS) of patients undergoing breast-conserving surgery (BCS) and mastectomy [1, 2]

  • This study aimed to evaluate the incidental irradiation dose to the internal mammary chain (IMC) in breast cancer patients after surgery and to estimate the clinical predictive parameters affecting the magnitude of the IMC

  • The incidental radiation dose to the IMC was 29.69 Gy, and the dose delivered to the IMC, ICS1, and ICS2 showed a greater coverage in the modified radical mastectomy (MRM) group when compared with the BCS group (32.85 vs. 27.1 Gy, 26.6 vs. 12.5 Gy, 34.63 vs. 30.42 Gy)

Read more

Summary

Introduction

Adjuvant breast cancer radiotherapy reduces the risk of local/ regional recurrence and improves overall survival (OS) of patients undergoing breast-conserving surgery (BCS) and mastectomy [1, 2]. In the Danish Breast Cancer Cooperative Group-IMN study, all patients with left-sided breast cancer were treated without IMNI (median follow-up period: 9.6 years), but a systematic review and metaanalysis proved that when IMNI was performed, patients with leftsided breast cancer were at a higher risk of cardiovascular (CV) death than those with right-sided breast cancer [6]. A 15-year analysis of the European Organization for Research and Treatment of Cancer (EORTC) 22922/10925 trial showed that IMC and supraclavicular fossa (SCF) lymph node chain irradiation significantly reduced breast cancer mortality and recurrence in patients with stage I–III breast cancer. This does not translate to improved OS, nor does it provide any indication of their late irradiation reactions [8].

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call